299 studies found for:    Open Studies | wake forest
Show Display Options
Rank Status Study
21 Recruiting Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65
Condition: Multiple Myeloma
Interventions: Drug: Lenalidomide;   Drug: Bortezomib;   Drug: Dexamethasone;   Procedure: Autologous Stem Cell Transplant
22 Recruiting Strength Training for ARthritis Trial
Condition: Knee Osteoarthritis
Interventions: Behavioral: High Intensity Strength Training;   Behavioral: Low Intensity Strength Training;   Behavioral: Attention Control
23 Recruiting A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint
Condition: Colon Cancer
Intervention:
24 Recruiting Safety and Efficacy of the Journey II BCS Total Knee System
Condition: Osteoarthritis, Knee
Intervention: Device: TKA with Journey II BCS Total Knee System
25 Recruiting Study to Evaluate the Efficacy and Safety of M518101 in Subjects With Plaque Psoriasis
Condition: Psoriasis
Interventions: Drug: M518101;   Drug: Vehicle
26 Recruiting Knee Arthroplasty Pain Coping Skills Training (KASTPain): A Randomized Trial
Condition: Knee Osteoarthritis
Interventions: Behavioral: Pain Coping Skills Training;   Behavioral: Arthritis Education;   Other: Usual Care
27 Recruiting A Clinical Trial for the Surgical Treatment of Elderly Distal Radius Fractures
Condition: Distal Radius Fracture
Interventions: Procedure: Open Reduction and Internal Fixation;   Procedure: External Fixation;   Procedure: Percutaneous Pinning;   Procedure: Closed Reduction and casting
28 Recruiting Clinical and Biological Predictors of Chemotherapy Toxicity in Older Adults
Condition: Breast Cancer
Intervention:
29 Recruiting Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis (ALS)
Intervention: Device: NeuRx® Diaphragm Pacing System™ (DPS)
30 Recruiting Safety, Tolerability and Efficacy Study of LiRIS® 400mg in Women With Interstitial Cystitis
Condition: Interstitial Cystitis
Interventions: Drug: LiRIS 400 mg;   Other: LiRIS Placebo
31 Recruiting Chemoradiation or Brachytherapy for Rectal Cancer
Condition: Rectal Cancer
Interventions: Radiation: Endo-HDR (if randomized to this arm);   Drug: capecitabine and IMRT (if randomized to this arm);   Radiation: IMRT (intensity modulated radiation therapy);   Drug: FOLFOX6;   Procedure: Surgery
32 Recruiting Effectiveness of Aprepitant in Addition to Ondansetron in the Prevention of Nausea and Vomiting Caused by Upper Abdominal Radiotherapy
Conditions: Nausea;   Vomiting
Interventions: Drug: aprepitant;   Drug: Ondansetron
33 Unknown  Mild Cognitive Impairment, Buddy Supported Exercise/ My Buddy Study
Conditions: Mild Cognitive Impairment;   Cognitive Disorders
Intervention: Behavioral: 5-month aerobic exercise intervention
34 Recruiting Immunotherapy Study for Patients With Stage IV Melanoma
Conditions: Stage IV Melanoma;   Metastatic Melanoma
Interventions: Drug: HyperAcute®-Melanoma (HAM) Immunotherapy;   Drug: Ipilimumab
35 Recruiting Screening of Healthy Adults for Genetic Variations That Control Fatty Acid Processing
Condition: Healthy
Intervention:
36 Recruiting Lifestyle Intervention for Treatment of Diabetes
Conditions: Type 2 Diabetes;   Overweight;   Obesity
Interventions: Behavioral: Community Lifestyle Weight Loss (LWL);   Behavioral: Diabetes Self Management (DSM)
37 Recruiting A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Conditions: Glioblastoma;   Small Cell Glioblastoma;   Giant Cell Glioblastoma;   Gliosarcoma;   Glioblastoma With Oligodendroglial Component;   Recurrent Glioblastoma;   Relapsed Glioblastoma
Interventions: Drug: Bevacizumab;   Drug: Rindopepimut (CDX-110) with GM-CSF;   Drug: KLH
38 Recruiting Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study)
Conditions: Pancreatic Neoplasms;   Digestive System Neoplasms;   Neoplasms by Site;   Neoplasms;   Endocrine Gland Neoplasms;   Pancreatic Diseases;   Digestive System Diseases;   Endocrine System Diseases;   Gemcitabine;   Antimetabolites, Antineoplastic
Interventions: Drug: nab-Paclitaxel 125 mg/m2;   Drug: gemcitabine 1000 mg/m2
39 Recruiting Immunotherapy Study in Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer
Conditions: Pancreatic Cancer;   Pancreatic Carcinoma Non-resectable;   Locally Advanced Malignant Neoplasm
Interventions: Drug: FOLFIRINOX;   Biological: Algenpantucel-L Immunotherapy;   Radiation: 5-FU Chemoradiation;   Drug: Gemcitabine;   Drug: Capecitabine;   Drug: Nab-Paclitaxel
40 Not yet recruiting A Trial of Rehabilitation Therapy in Older Acute Heart Failure Patients
Condition: Acute Decompensated Heart Failure
Interventions: Behavioral: multi-domain rehabilitation intervention;   Behavioral: Attention Control

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years